LTRN
Lantern Pharma Inc.
$4.01
+$0.04(+1.01%)
33
Overall
60
Value
20
Tech
21
Quality
Market Cap
$42.98M
Volume
32.32K
52W Range
$2.55 - $6.12
Target Price
$25.00
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | -- | -- | -- | $8.5M | $11.4M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | $-8.5M | $-11.4M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $5.9M | $12.6M | $14.4M | $17.9M | $22.2M | ||
| Research & Development | $2.2M | $7.6M | $8.6M | $11.9M | $16.1M | ||
| Research Expense | $2.2M | $7.6M | $8.6M | $11.9M | $16.1M | ||
| Selling, General & Administrative | $3.7M | $5.0M | $5.8M | $6.0M | $6.1M | ||
| General & Administrative Expenses | $3.7M | $5.0M | $5.8M | $6.0M | $6.1M | ||
| Salaries & Wages | -- | $961.5K | $1.2M | $1.0M | $652.0K | ||
| Amortization | -- | $88.5K | $138.3K | $160.2K | $173.2K | ||
| Other Operating Expenses | $5.9M | $12.6M | $144.0K | $192.0K | $210.0K | ||
| OPERATING INCOME | |||||||
| Operating income | $-11.8M | $-12.6M | $-14.4M | $-17.9M | $-22.2M | ||
| EBITDA | $-11.8M | $-12.6M | $-14.4M | $-15.9M | $-20.8M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | -- | $67.9K | $204.4K | $765.4K | $742.4K | ||
| Net Non-Operating Interest Income/Expense | -- | $67.9K | $204.4K | $765.4K | $742.4K | ||
| Other Income/Expense | -- | $-160.6K | $-31.5K | $-1.2M | $-692.9K | ||
| Other Special Charges | -- | $160.6K | $-31.5K | $1.2M | $692.9K | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-11.8M | $-12.6M | $-14.4M | $-16.0M | $-20.8M | ||
| Pre-Tax Income | $-11.8M | $-12.4M | $-14.3M | $-16.0M | $-20.8M | ||
| NET INCOME | |||||||
| Net Income | $-5.9M | $-12.4M | $-14.3M | $-16.0M | $-20.8M | ||
| Net Income (Continuing Operations) | $-5.9M | $-12.4M | $-14.3M | $-16.0M | $-20.8M | ||
| Net Income (Discontinued Operations) | $-5.9M | $-12.4M | $-14.3M | $-16.0M | $-20.8M | ||
| Net Income (Common Stockholders) | $-11.8M | $-12.4M | $-14.3M | $-16.0M | $-20.8M | ||
| Normalized Income | -- | $-9.8M | -- | -- | $-20.6M | ||
| TOTALS | |||||||
| Total Expenses | $5.9M | $12.6M | $14.4M | $26.3M | $33.6M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $4.3M | $10.9M | $10.9M | $10.8M | $10.8M | ||
| Average Shares Outstanding (Diluted) | $4.3M | $10.9M | $10.9M | $10.8M | $10.8M | ||
| Shares Outstanding | $10.8M | $10.8M | $10.9M | $10.7M | $10.8M | ||
| Basic EPS | $-1.37 | $-1.13 | $-1.31 | $-1.47 | $-1.93 | ||
| Basic EPS (Continuing Operations) | $-1.37 | $-1.13 | $-1.31 | $-1.47 | $-1.93 | ||
| Diluted EPS | $-1.37 | $-1.13 | $-1.31 | $-1.47 | $-1.93 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-1.47 | $-1.93 | ||
| OTHER METRICS | |||||||
| Minority Interests | $-5.9M | $-12.4M | -- | -- | -- | ||
| Other Gand A | $3.7M | $5.0M | $5.8M | $6.0M | $6.1M | ||
| Rent And Landing Fees | -- | $2.0K | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LTRN | $4.01 | +1.0% | 32.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |